McFalls E O, Duncker D J, Sassen L M, Gho B C, Verdouw P D
Laboratory for Experimental Cardiology, Erasmus University Rotterdam, The Netherlands.
J Cardiovasc Pharmacol. 1991 Dec;18(6):827-36. doi: 10.1097/00005344-199112000-00007.
The effect of nifedipine (0.5, 1.0, and 2.0 micrograms/kg/min), metoprolol (0.1, 0.5, and 1.0 mg/kg), the beta 1-selective adrenoceptor partial agonist epanolol (10, 50, and 200 micrograms/kg), or equivalent volumes of isotonic saline (n = 6, in each group), on coronary blood flow capacity were studied in anesthetized swine. Intracoronary bolus injections of adenosine (20 micrograms/kg/0.2 ml) were administered without and during three levels of coronary stenosis, prior to and following each dose of drug, to obtain maximal coronary blood flows at different perfusion pressures in the autoregulatory range. Coronary perfusion pressures were varied by partial inflation of a balloon around the left anterior descending coronary artery. Special care was taken that the stenoses not lead to myocardial ischemia. Three indices of coronary blood flow capacity were used: absolute coronary flow reserve (ACFR, the ratio of maximal to resting coronary blood flow), the slope and the extrapolated pressure at zero flow (Pzf) of the pressure-maximal coronary flow (PMCF) relationship, and relative coronary flow reserve (RCFR, the ratio of maximal coronary blood flow with a stenosis to maximal coronary blood flow without a stenosis) at two of the three levels of stenosis. Nifedipine decreased ACFR from 4.5 +/- 1.9 to 1.9 +/- 0.3 (mean +/- SD; p less than 0.05), reflecting in part the increase in resting coronary blood flow. The nifedipine-induced changes in maximal coronary blood flow were not only due to a drop in perfusion pressure, as the slope of the PMCF relationship decreased from 2.27 +/- 0.49 ml/(min.mm Hg) to 1.54 +/- 0.51 ml/(min.mm Hg) (p less than 0.05), and Pzf decreased from 30 +/- 4 mm Hg to 20 +/- 7 mm Hg (p less than 0.05). Consequently, calculated maximal coronary blood flow was attenuated from 114 +/- 31 ml/min to 93 +/- 37 ml/min at 80 mm Hg, but was enhanced from 23 +/- 13 to 37 +/- 24 ml/min at 40 mm Hg coronary perfusion pressure. In concert with the change in the PMCF relationship, RCFR at equivalent severe stenosis increased from 0.33 +/- 0.06 to 0.47 +/- 0.10 (p less than 0.05). No changes were observed with metoprolol, epanolol, or saline. The effect of nifedipine on the PMCF relationship not only provides a mechanism for the drug's antiischemic action, but should also be considered in the interpretation of coronary flow reserve measurements in patients on nifedipine treatment.
在麻醉猪身上研究了硝苯地平(0.5、1.0和2.0微克/千克/分钟)、美托洛尔(0.1、0.5和1.0毫克/千克)、β1选择性肾上腺素能受体部分激动剂依泮洛尔(10、50和200微克/千克)或等体积的等渗盐水(每组n = 6)对冠状动脉血流容量的影响。在每次给药前和给药后,在无冠状动脉狭窄和三种程度的冠状动脉狭窄期间,冠状动脉内推注腺苷(20微克/千克/0.2毫升),以获得自动调节范围内不同灌注压力下的最大冠状动脉血流。通过在左前降支冠状动脉周围部分充盈球囊来改变冠状动脉灌注压力。特别注意确保狭窄不会导致心肌缺血。使用了三个冠状动脉血流容量指标:绝对冠状动脉血流储备(ACFR,最大冠状动脉血流与静息冠状动脉血流之比)、压力-最大冠状动脉血流(PMCF)关系的斜率和零流量时的外推压力(Pzf),以及在三种狭窄程度中的两种程度下的相对冠状动脉血流储备(RCFR,有狭窄时的最大冠状动脉血流与无狭窄时的最大冠状动脉血流之比)。硝苯地平使ACFR从4.5±1.9降至1.9±0.3(平均值±标准差;p<0.05),部分反映了静息冠状动脉血流的增加。硝苯地平引起的最大冠状动脉血流变化不仅是由于灌注压力下降,因为PMCF关系的斜率从2.27±0.49毫升/(分钟·毫米汞柱)降至1.54±0.51毫升/(分钟·毫米汞柱)(p<0.05),且Pzf从30±4毫米汞柱降至20±7毫米汞柱(p<0.05)。因此,在80毫米汞柱时计算出的最大冠状动脉血流从114±31毫升/分钟降至93±37毫升/分钟,但在冠状动脉灌注压力为40毫米汞柱时从23±13毫升/分钟增加至37±24毫升/分钟。与PMCF关系的变化一致,在同等严重狭窄时RCFR从0.33±0.06增加至0.47±0.10(p<0.05)。美托洛尔、依泮洛尔或盐水未观察到变化。硝苯地平对PMCF关系的影响不仅为该药物的抗缺血作用提供了一种机制,而且在解释接受硝苯地平治疗的患者的冠状动脉血流储备测量结果时也应予以考虑。